Novolog Penfill Coupons & Prices

Novolog Penfill FAQs

How much does Novolog Penfill cost without insurance?

At most pharmacies, the average cost of Novolog Penfill is $696.31 for 5, 3ML of 100UNIT/ML Cartridge. That same prescription may cost $27.96 for 1, 3ml of 100unit/ml Cartridge using a SingleCare savings card, which you can use at major pharmacies throughout the country. Still, retail prices may vary based on pharmacy location and other factors. 

How much does Novolog Penfill cost with insurance?

The costs of Novolog Penfill with insurance vary depending on your insurance plan. You may be required to pay a copay or coinsurance amount. In some cases, you may be responsible for the full cost of the drug if you've not met your deductible. It's best to consult your insurance plan or your pharmacy for more information. With a SingleCare discount card, you could save more than you would with insurance. 

 Does Medicare cover Novolog Penfill and how much does it cost?

Medicare Advantage and Medicare Part D prescription drug insurance plans may provide coverage for Novolog Penfill. Check with your plan’s formulary or contact your local pharmacy to determine the potential cost with Medicare. If you do not have Medicare prescription drug coverage, you could use a SingleCare Novolog Penfill coupon for your prescription. With SingleCare, the current discounted price of Novolog Penfill is $27.96 for 1, 3ml of 100unit/ml Cartridge.

Is there a generic of Novolog Penfill?

Novolog Penfill is a brand-name insulin product with insulin aspart as the active ingredient. Various forms of Novolog may be available as a generic. 

What is Novolog Penfill?

Novolog Penfill is an insulin pen injection cartridge with 300 units (3 mL) of insulin aspart. The cartridges are available by prescription only and serve as refills for a compatible insulin delivery device, such as the Novolog Echo.

Novolog is prescribed as a mealtime insulin injection to patients with Type 1 or Type 2 diabetes to control high blood sugar levels. Insulin aspart is a rapid-acting insulin that begins working within 15 minutes of an injection. It works by mimicking natural insulin to facilitate the uptake of sugar by cells. 

Consult a healthcare provider or doctor on the appropriate dosage based on blood sugar levels and overall condition. People who use insulin may need to regularly monitor blood glucose levels. 

What are the side effects of Novolog Penfill?

Common side effects of {{drug}} include, but are not limited to:

• Low blood sugar levels (hypoglycemia), which may cause symptoms like headache, confusion, sweating, irritability, shakiness, hunger, and dizziness

• Injection site reactions, such as itching, redness, and swelling

• Skin thickening at the injection site

• Swelling of the hands and feet

• Weight gain

Serious side effects may include:

• Severe hypoglycemia

• Signs of an allergic reaction, such as hives, rash, and trouble breathing

• Low potassium (hypokalemia), which may cause shortness of breath, irregular heartbeat, and death

Seek immediate medical attention if you experience severe adverse effects, including trouble breathing, extreme dizziness or confusion, and fast heartbeat. This is not a complete list of side effects. Consult your healthcare provider for medical and additional information about possible side effects, interactions, and precautions.

Does Novolog Penfill need to be refrigerated?

Unused or unopened Novolog pens and vials must be stored in the refrigerator at 36°F to 46°F until expiration. Novolog Penfill that are opened and in use should not be returned to the refrigerator. In-use FlexPen and PenFill cartridges should be kept at room temperature for up to 28 days. 

What is biosimilar insulin? 

Biosimilar insulin is a type of insulin that is very similar in function to an already approved insulin product. However, it's not considered a generic equivalent. Novolog does not currently have any approved biosimilars. A Novolog biosimilar known as MYL-1601D is under investigation for approval in the United States, although a release date for the Novolog biosimilar is undetermined.